These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 8808186

  • 1. Do changes in clinical improvement in rheumatoid arthritis patients treated with immunosuppressive drugs reflect the changes in acute phase proteins?
    Lacki JK, Samborski W, Mackiewicz S, Mackiewicz U.
    Ups J Med Sci; 1995; 100(3):233-42. PubMed ID: 8808186
    [Abstract] [Full Text] [Related]

  • 2. Acute phase response in rheumatoid arthritis patients treated with immunosuppressive drugs.
    Lacki JK, Klama K, Samborski W, Mackiewicz S, Mackiewicz U, Muller W.
    Mater Med Pol; 1995; 27(2):47-51. PubMed ID: 8935189
    [Abstract] [Full Text] [Related]

  • 3. Immunological studies in patients with rheumatoid arthritis treated with methotrexate or cyclophosphamide.
    Lacki JK, Schochat T, Sobieska M, Leszczynski P, Wiktorowicz K, Mackiewicz U, Mackiewicz SH, Müller W.
    Z Rheumatol; 1994; 53(2):76-82. PubMed ID: 8023589
    [Abstract] [Full Text] [Related]

  • 4. Interleukin 10 inhibits interleukin 6 production and acute phase response in rheumatoid arthritis.
    Lacki JK, Klama K, Porawska W, Mackiewicz SH, Müller W, Wiktorowicz K.
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):11-4. PubMed ID: 8744678
    [Abstract] [Full Text] [Related]

  • 5. Acute-phase response in early refractory rheumatoid arthritis: long-term follow-up study.
    Lacki JK, Porawska W, Mackiewicz SH, Muller W.
    J Investig Allergol Clin Immunol; 1994; 4(4):168-71. PubMed ID: 7531580
    [Abstract] [Full Text] [Related]

  • 6. Effects of low dose methotrexate therapy on the concentration and the glycosylation of alpha 1-acid glycoprotein in the serum of patients with rheumatoid arthritis: a longitudinal study.
    De Graaf TW, Van Ommen EC, Van der Stelt ME, Kerstens PJ, Boerbooms AM, Van Dijk W.
    J Rheumatol; 1994 Dec; 21(12):2209-16. PubMed ID: 7699621
    [Abstract] [Full Text] [Related]

  • 7. [The quantitative evaluation of the serum acute phase proteins (APP) of patients undergoing a curative resection for non-small cell lung cancer (NSCLC)].
    Kasprzyk M, Dyszkiewicz W, Zwaruń D, Szydlik S, Leśniewska K, Krzyzanowski M.
    Przegl Lek; 2006 Dec; 63(10):936-40. PubMed ID: 17288188
    [Abstract] [Full Text] [Related]

  • 8. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis.
    Garnero P, Gineyts E, Christgau S, Finck B, Delmas PD.
    Arthritis Rheum; 2002 Jan; 46(1):21-30. PubMed ID: 11817593
    [Abstract] [Full Text] [Related]

  • 9. Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy.
    Ferraccioli G, Casatta L, Bartoli E.
    J Rheumatol; 1996 Sep; 23(9):1539-42. PubMed ID: 8877921
    [Abstract] [Full Text] [Related]

  • 10. A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment.
    Durez P, Nzeusseu Toukap A, Lauwerys BR, Manicourt DH, Verschueren P, Westhovens R, Devogelaer JP, Houssiau FA.
    Ann Rheum Dis; 2004 Sep; 63(9):1069-74. PubMed ID: 15308515
    [Abstract] [Full Text] [Related]

  • 11. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI, Morgan SL, Smith HT, Robbins BA, Choc MG, Baggott JE.
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [Abstract] [Full Text] [Related]

  • 12. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 13. Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis.
    Posthumus MD, Limburg PC, Westra J, van Leeuwen MA, van Rijswijk MH.
    J Rheumatol; 2002 May; 29(5):883-9. PubMed ID: 12022344
    [Abstract] [Full Text] [Related]

  • 14. Studies on microheterogeneity of acute-phase proteins in rheumatoid arthritis by using crossed affinoimmuno-electrophoresis with free concanavalin A.
    Pawłowski T, Mackiewicz A, Mackiewicz S.
    Behring Inst Mitt; 1986 Jun; (80):11-5. PubMed ID: 2428350
    [Abstract] [Full Text] [Related]

  • 15. Reduced burden of disease and improved outcome of patients with rheumatoid factor positive rheumatoid arthritis compared with dropouts. A 10 year observational study.
    Darmawan J, Rasker JJ, Nuralim H.
    J Rheumatol Suppl; 2003 Aug; 67():50-3. PubMed ID: 12926656
    [Abstract] [Full Text] [Related]

  • 16. Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis.
    Cylwik B, Chrostek L, Gindzienska-Sieskiewicz E, Sierakowski S, Szmitkowski M.
    Adv Med Sci; 2010 Aug; 55(1):80-5. PubMed ID: 20371432
    [Abstract] [Full Text] [Related]

  • 17. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D, Park GS, Paulus HE, Simpson KM, Elashoff D, Cohen SB, Emery P, Dorrier C, Furst DE.
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [Abstract] [Full Text] [Related]

  • 18. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
    González-Gay MA, Hajeer AH, García-Porrúa C, Dababneh A, Thomson W, Ollier WE, Mattey DL.
    J Rheumatol; 2002 Feb; 29(2):271-5. PubMed ID: 11842822
    [Abstract] [Full Text] [Related]

  • 19. Validity of acute phase proteins as markers of disease activity.
    Blackburn WD.
    J Rheumatol Suppl; 1994 Oct; 42():9-13. PubMed ID: 7529838
    [Abstract] [Full Text] [Related]

  • 20. Short term effects of low dose methotrexate on the acute phase reaction in patients with rheumatoid arthritis.
    Segal R, Caspi D, Tishler M, Wigler I, Yaron M.
    J Rheumatol; 1989 Jul; 16(7):914-7. PubMed ID: 2504917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.